This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Olivier Ganier: Innovator in Stem Cell Research
Introduction
Olivier Ganier is a prominent inventor based in Montpellier, France. He has made significant contributions to the field of stem cell research, particularly through his innovative patent that focuses on the use of cellular extracts for obtaining pluripotent stem cells. His work is vital in advancing medical science and regenerative medicine.
Latest Patents
Olivier Ganier holds a patent titled "Use of cellular extracts for obtaining pluripotent stem cells." This patent describes a method that utilizes a composition including at least one permeabilized nucleus of a first cell, or at least one permeabilized first cell containing the nucleus and an extract of female germinal cells, or eggs, of a multicellular organism. The eggs are blocked in the metaphase II of meiosis, and the extract includes EGTA. This innovative process is aimed at obtaining pluripotent stem cells or tissues derived from them, while ensuring that the process is not intended for cloning human beings. He has 1 patent to his name.
Career Highlights
Olivier Ganier is affiliated with the Centre National de la Recherche Scientifique, a leading research institution in France. His work at this esteemed organization has allowed him to explore and develop groundbreaking techniques in stem cell research. His dedication to scientific advancement is evident in his innovative approaches and research methodologies.
Collaborations
Olivier Ganier collaborates with notable scientists in his field, including Marcel Mechali. Their partnership enhances the research efforts and contributes to the development of new techniques in stem cell technology.
Conclusion
Olivier Ganier's contributions to stem cell research through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to impact regenerative medicine significantly.
